Skip to main content

Aquestive Therapeutics, Inc.

AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001398733

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Aquestive Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of AQST: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4652+6
Shares14.8M16.2M+1.38M (+9.4%)
Value$64.4M$62.9M−$1.57M (−2.4%)

New holders (13)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to AQST in Q4 2021
InstitutionSharesValue% of portfolio
Vahanian & Associates Financial Planning Inc.929,975$3.62M2.92%
Schonfeld Strategic Advisors LLC105,700$411.0K0.00%
Simplex Trading, LLC88,253$343.0K0.01%
D. E. Shaw & Co., Inc.87,786$341.0K0.00%
Virtu Financial LLC79,138$308.0K0.03%
Caxton Associates LP42,028$163.0K0.02%
Engineers Gate Manager LP37,500$146.0K0.01%
Cubist Systematic Strategies, LLC29,926$116.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.28,382$110.0K0.00%
ExodusPoint Capital Management, LP24,475$95.0K0.00%
Man Group plc18,517$72.0K0.00%
Tower Research Capital LLC (TRC)1,788$7.00K0.00%
Citigroup Inc1,190$5.00K0.00%

Sold out (7)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of AQST in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Balyasny Asset Management LLC148,061$646.0K
Brandywine Global Investment Management, LLC125,016$545.0K
Jump Financial, LLC49,700$216.0K
Quantbot Technologies LP1,400$6.00K
Harbour Investments, Inc.225$1.00K
Cutler Group LP300$1.00K
Deutsche Bank AG21$0